Gapping down
In reaction to earnings/guidance:
- PHG -16%, JEF -2.4%, DGX -1.9%, UTRS -0.7%
Other news:
- HYZN -10.7% (discloses that it received a subpoena from the SEC for production of documents and information including related to the allegations made in the report issued by Blue Orca Capital)
- BIIB -9% (Medicare proposes to cover Aduhelm only for patients in clinical trials according to NYT)
- IAG -5.8% (reports FY21 production and FY22 production guidance)
- RC -4% (prices offering of 7 mln shares of common stock for gross proceeds of $108.9 mln)
- LLY -3.6% (in sympathy with BIIB news)
- NSR -3.4% (entered into an agreement with a syndicate of underwriters that have agreed to buy on a bought deal basis 4400000 common shares at C$9.10 per Common Share)
- ACRS -2.8% (Chief Medical Officer has stepped down; also provides R&D update)
Analyst comments:
- KTOS -3.8% (downgraded to Neutral from Buy at Goldman)
- PYPL -1.9% (downgraded to Hold from Buy at Jefferies)
- PFC -1% (downgraded to Neutral from Overweight at Piper Sandler)
- LUV -0.6% (downgraded to Peer Perform from Outperform at Wolfe Research)